- Author:
Jie HUANG
1
;
Dong-Ping HUANG
1
;
Yu-Qiong YANG
1
;
Xiao-Ke JIN
1
;
He-Sheng PAN
2
Author Information
- Publication Type:Case Reports
- MeSH: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large B-Cell, Diffuse; Prognosis; Retrospective Studies
- From: Journal of Experimental Hematology 2018;26(4):1067-1071
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore clinical characteristics of the Primary Adrenal Lymphoma(PAL), so as to enhance the understanding of diagnosis, treatment and prognosis of PAL.
METHODSThe clinical data of 2 patients with PAL retrospectively analyzed and the clinical characteristics were explored in combination with releted literalures.
RESULTSAdrenal gland neoplasm was found in 2 patients by imaging examination. The pathological type of one case was diffuse large B cell lymphoma, the other one was extranodal NK/T-cell lymphoma. The former refused to hosipitali3t and the other received to be admited in hospital after the definite diagnosis. She died at the 32th day after diagnosis, due to the complication with acute pancreatitis before chemotherapy. The latter accepted the scheme of"Gemox"combining with the scheme"VP-16+DXM"to control hemophagocytic lymphohistiocytosis. The patient's condition deteriorated rapidly after a short period of improvement, then died at the 40th day after chemotherapy because of multiple organ failure.
CONCLUSIONPAL is a rare extra-nodal lymphoma with higher malignancy, the combination of chemotherapy and radiotherapy results in the best outcome among all the treatments. The prognosis of patients with different pathological types was diverse, thus it is very important to choose the appropriate treatment according to different pathological types.